Page 250 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 250
Viral Hepatitis: Hepatitis C - Clinical (Except Therapy) (Cont.)
P0751 POLYMORPHISMS IN THE FAS PROMOTER REGION ARE
NOT ASSOCIATED WITH FIBROSIS PROGRESSION IN
HCV- 1 AND 4 PATIENTS
Stella De Nicola*, Enrico Galmozzi, Roberta D’Ambrosio,
Alessio Aghemo, Riccardo Perbellini, Eleonora Grassi,
Massimo Colombo, Italy
TOP 10% NOTCH4 AND MHC CLASS II POLYMORPHISMS
YI P0752 CONTIBUTE TO HCV-RELATED BENIGN AND MALIGNANT
LYMPHOPROLIFERATIVE DISEASES
Alessia Piluso*, Laura Gragnani, Alessandro Genovesi, Valli De Re,
Massimo Libra, Anna Linda Zignego, Italy
YI P0753 GENETIC POLYMORPHISMS OF IL28B AND PNPLA3 ARE
CLOSELY ASSOCIATED WITH FIBROSIS PROGRESSION IN
CHRONIC HEPATITIS C
Nobuharu Tamaki*, Masayuki Kurosaki,Yutaka Yasui, Shoko Suzuki,
Takanori Hosokawa, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura,
Namiki Izumi, Japan
YI P0754 CLINICAL SIGNIFICANCE OF DRUG-DRUG INTERACTIONS
DURING THERAPY WITH NOVEL DAAS AGAINST HCV
ePOSTERS Christoph Hoener Zu Siederdissen*, Benjamin Maasoumy, Fiona Marra,
Katja Deterding, Kerstin Port, Michael P. Manns, Markus Cornberg,
David Back, Heiner Wedemeyer, Germany
YI P0755 HEPATITIS C INFECTION IS ASSOCIATED WITH AN
INCREASE IN CARDIOVASCULAR DISEASES
Firew Wubiee*, Charles Howell, The United States
YI P0756 HEPATITIS C REINFECTION RATES FOLLOWING
TREATMENT INDUCED SVR IN PATIENTS WHO ACTIVELY
INJECT DRUGS AT THE TIME OF TREATMENT
Joanne M. Baxter*, Arpana Verma, F Javier Vilar, The United Kingdom
YI P0757 EXPRESSION OF INHIBITORY CD158B AND CD158E NK
YI P0758 CELL RECEPTORS IS ASSOCIATED WITH SIGNIFICANT
LIVER INJURY IN THE COURSE OF CHRONIC HEPATITIS C
IN CHILDREN
Anna Mania*, Mariusz Kaczmarek, Paweł Kemnitz, Iwona Mozer-
Lisewska, Magdalena Figlerowicz, Jan Sikora, Wojciech Sluzewski,
Jan Żeromski, Poland
THE RELATIONSHIP BETWEEN HEPATITIS C RELATED
LIVER DISEASE WITH DIABETES MELLITUS AND VITAMIN D
Varun Gupta*, Ashish Kumar, Praveen Sharma, Anil Arora, India
250 The International Liver Congress™ 2015 • ILC Programme
P0751 POLYMORPHISMS IN THE FAS PROMOTER REGION ARE
NOT ASSOCIATED WITH FIBROSIS PROGRESSION IN
HCV- 1 AND 4 PATIENTS
Stella De Nicola*, Enrico Galmozzi, Roberta D’Ambrosio,
Alessio Aghemo, Riccardo Perbellini, Eleonora Grassi,
Massimo Colombo, Italy
TOP 10% NOTCH4 AND MHC CLASS II POLYMORPHISMS
YI P0752 CONTIBUTE TO HCV-RELATED BENIGN AND MALIGNANT
LYMPHOPROLIFERATIVE DISEASES
Alessia Piluso*, Laura Gragnani, Alessandro Genovesi, Valli De Re,
Massimo Libra, Anna Linda Zignego, Italy
YI P0753 GENETIC POLYMORPHISMS OF IL28B AND PNPLA3 ARE
CLOSELY ASSOCIATED WITH FIBROSIS PROGRESSION IN
CHRONIC HEPATITIS C
Nobuharu Tamaki*, Masayuki Kurosaki,Yutaka Yasui, Shoko Suzuki,
Takanori Hosokawa, Kaoru Tsuchiya, Hiroyuki Nakanishi, Jun Itakura,
Namiki Izumi, Japan
YI P0754 CLINICAL SIGNIFICANCE OF DRUG-DRUG INTERACTIONS
DURING THERAPY WITH NOVEL DAAS AGAINST HCV
ePOSTERS Christoph Hoener Zu Siederdissen*, Benjamin Maasoumy, Fiona Marra,
Katja Deterding, Kerstin Port, Michael P. Manns, Markus Cornberg,
David Back, Heiner Wedemeyer, Germany
YI P0755 HEPATITIS C INFECTION IS ASSOCIATED WITH AN
INCREASE IN CARDIOVASCULAR DISEASES
Firew Wubiee*, Charles Howell, The United States
YI P0756 HEPATITIS C REINFECTION RATES FOLLOWING
TREATMENT INDUCED SVR IN PATIENTS WHO ACTIVELY
INJECT DRUGS AT THE TIME OF TREATMENT
Joanne M. Baxter*, Arpana Verma, F Javier Vilar, The United Kingdom
YI P0757 EXPRESSION OF INHIBITORY CD158B AND CD158E NK
YI P0758 CELL RECEPTORS IS ASSOCIATED WITH SIGNIFICANT
LIVER INJURY IN THE COURSE OF CHRONIC HEPATITIS C
IN CHILDREN
Anna Mania*, Mariusz Kaczmarek, Paweł Kemnitz, Iwona Mozer-
Lisewska, Magdalena Figlerowicz, Jan Sikora, Wojciech Sluzewski,
Jan Żeromski, Poland
THE RELATIONSHIP BETWEEN HEPATITIS C RELATED
LIVER DISEASE WITH DIABETES MELLITUS AND VITAMIN D
Varun Gupta*, Ashish Kumar, Praveen Sharma, Anil Arora, India
250 The International Liver Congress™ 2015 • ILC Programme
